Patents by Inventor Philip Edwards

Philip Edwards has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10990689
    Abstract: Systems and methods for governing access to or use of assets in an analytics platform. Access to assets is controlled with policies that reference attributes. A context of an access request is defined by collecting attributes associated with an access request. The context is then evaluated in light of attributes referenced by the policy applicable to the asset or with a class of the asset. The access request is granted, denied, or partially granted based on whether the attributes defined by the context of the access request comport with the policy.
    Type: Grant
    Filed: March 31, 2016
    Date of Patent: April 27, 2021
    Assignee: EMC IP HOLDING COMPANY LLC
    Inventors: David Reiner, Nihar Nanda, Philip Edwards
  • Patent number: 10941002
    Abstract: A telescopic conveyor includes a conveyor boom having two or more conveyor sections adapted to be extended and retracted with respect to one another in telescopic fashion to adjust the length of the boom, wherein the two or more conveyor sections are each curved about a common axis of curvature.
    Type: Grant
    Filed: June 14, 2018
    Date of Patent: March 9, 2021
    Assignee: Telestack Limited
    Inventor: Philip Edwards
  • Publication number: 20200148477
    Abstract: A telescopic conveyor includes a conveyor boom having two or more conveyor sections adapted to be extended and retracted with respect to one another in telescopic fashion to adjust the length of the boom, wherein the two or more conveyor sections are each curved about a common axis of curvature.
    Type: Application
    Filed: June 14, 2018
    Publication date: May 14, 2020
    Inventor: Philip Edwards
  • Patent number: 8604029
    Abstract: The invention provides compounds of formula (I), and pharmaceutically acceptable salts thereof wherein: R1, R2, R3, R4, R5, R6, R7, X and X1 are as defined herein. These compounds are useful in the manufacture of medicaments for use in the prevention or treatment of a fungal disease. Compounds of formula (I), and agriculturally acceptable salts thereof, may also be used as agricultural fungicides.
    Type: Grant
    Filed: November 21, 2007
    Date of Patent: December 10, 2013
    Assignee: F2G Ltd British Body Corporate
    Inventors: Robert Downham, Graham Edward Morris Sibley, Lloyd James Payne, Philip Edwards, Gareth Morse Davies
  • Patent number: 8524705
    Abstract: The invention provides compounds of formula (I), and pharmaceutically and agriculturally acceptable salts thereof: wherein: R1, R2, R3, R4, R5, R6, R7, R8, A1, L1 and n are as defined herein. These compounds and their pharmaceutically acceptable salts are useful in the manufacture of medicaments for use in the prevention or treatment of a fungal disease. Compounds of formula (I), and agriculturally acceptable salts thereof, may also be used as agricultural fungicides.
    Type: Grant
    Filed: May 21, 2008
    Date of Patent: September 3, 2013
    Assignee: F2G Limited British Body Corporate
    Inventors: Lloyd James Payne, Robert Downham, Graham Edward Morris Sibley, Philip Edwards, Gareth Morse Davies
  • Publication number: 20110160184
    Abstract: Compounds the following formula: wherein Z is as described in the specification, pharmaceutically acceptable salts thereof, compositions comprising the same, and methods of treating bipolar disorder, an anxiety disorder, a mood disorder or schizophrenia or other psychotic disorder with said compounds.
    Type: Application
    Filed: June 18, 2009
    Publication date: June 30, 2011
    Applicant: ASTRAZENECA AB
    Inventors: Dean Brown, Steven Wesolowski, Dan Widzowski, James R. Damewood, M. Edward Pierson, Jr., Michael Wood, Philip Edwards, James Hulsizer, Ashokkumar Bhikkappa Shenvi, James Campbell Muir
  • Publication number: 20110009390
    Abstract: The invention provides compounds of formula (I), and pharmaceutically and agriculturally acceptable salts thereof: wherein: R1, R2, R3, R4, R5, R6, R7, R8, A1, L1 and n are as defined herein. These compounds and their pharmaceutically acceptable salts are useful in the manufacture of medicaments for use in the prevention or treatment of a fungal disease. Compounds of formula (I), and agriculturally acceptable salts thereof, may also be used as agricultural fungicides.
    Type: Application
    Filed: May 21, 2008
    Publication date: January 13, 2011
    Applicant: F2G LIMITED
    Inventors: Lloyd James Payne, Robert Downham, Graham Edward Morris Sibley, Philip Edwards, Gareth Morse Davies
  • Publication number: 20090312322
    Abstract: The present invention relates to a new use of oxindole derivatives of formula I, as a free base or a pharmaceutically acceptable salt thereof, [Chemical formula should be inserted here. Please see paper copy.] wherein R1, R2, R3, m and n are as defined as in claim 1, as well as to new compounds, a process for their preparation and new intermediates used in the preparation thereof, pharmaceutical compositions containing said therapeutically active compounds and to the use of said active compounds in therapy, especially in the prevention and/or treatment of dementia related diseases, Alzheimer's Disease and conditions associated with glycogen synthase kinase-3.
    Type: Application
    Filed: December 9, 2008
    Publication date: December 17, 2009
    Applicant: AstraZeneca AB
    Inventors: Stefan Berg, Ratan Bhat, Philip Edwards, Sven Hellberg
  • Patent number: 7342022
    Abstract: The present invention relates to new compounds of formula I wherein R1, R2, R3, n, m are defined as in claim 1, a process for their preparation and new intermediates used in the preparation thereof, pharmaceutical formulations containing said therapeutically active compounds and to the use of said active compounds in therapy, especially in the prevention and/or treatment of dementia related diseases, Alzheimer's Disease and conditions associated with glycogen synthase kinase-3
    Type: Grant
    Filed: December 18, 2002
    Date of Patent: March 11, 2008
    Assignee: AstraZeneca AB
    Inventors: Stefan Berg, Ratan Bhat, Philip Edwards, Sven Hellberg
  • Publication number: 20070074670
    Abstract: A pet food container assembly having a container which is dimensioned to enclose pet food. A noisemaker is attached to the pet food container and the noisemaker is selectively activated by a user prior to dispensing food from the container to the pet in order to train the pet.
    Type: Application
    Filed: October 5, 2005
    Publication date: April 5, 2007
    Inventor: Philip Edwards
  • Publication number: 20060201446
    Abstract: A lightweight, highly resilient floatable animal chew toy having a body made of elastomeric material, a density of less than 0.95 g/cm3 and a tensile strength of at least 2.0 MPa.
    Type: Application
    Filed: March 10, 2006
    Publication date: September 14, 2006
    Inventor: Philip Edwards
  • Publication number: 20060102099
    Abstract: In at least one embodiment, the present invention relates to a polymeric dog bone comprising an elongated central body portion having an end portion. At least one end member extends from the end portion of the central body portion. In at least one embodiment, the end member has a first surface, a second surface, a plurality of first-shaped features located on the first surface, and a plurality of second-shaped features having a different shape than the first-shaped features located on the second surface.
    Type: Application
    Filed: November 12, 2004
    Publication date: May 18, 2006
    Inventor: Philip Edwards
  • Publication number: 20050222181
    Abstract: The present invention relates to new compounds of formula I wherein R1, R2, R3, n, m are defined as in claim 1, a process for their preparation and new intermediates used in the preparation thereof, pharmaceutical formulations containing said therapeutically active compounds and to the use of said active compounds in therapy, especially in the prevention and/or treatment of dementia related diseases, Alzheimer's Disease and conditions associated with glycogen synthase kinase-3.
    Type: Application
    Filed: December 18, 2002
    Publication date: October 6, 2005
    Inventors: Stefan Berg, Ratan Bhat, Philip Edwards, Sven Hellberg
  • Publication number: 20050070559
    Abstract: The present invention relates to a new use of oxindole derivatives of formula I, as a free base or a pharmaceutically acceptable salt thereof, wherein R1, R2, R3, m and n arm as defined as in claim 1, as well as to new compounds, a process for their preparation and new intermediates used in the preparation thereof, pharmaceutical compositions containing said therapeutically active compounds and to the use of said active compounds in therapy, especially in the prevention and/or treatment of dementia related diseases, Alzheimer's Disease and conditions associated with glycogen synthase kinase-3.
    Type: Application
    Filed: December 18, 2002
    Publication date: March 31, 2005
    Inventors: Stefan Berg, Ratan Bhat, Philip Edwards, Sven Hellberg
  • Patent number: 4261817
    Abstract: In a sieving apparatus a suction chamber is connected to a source of vacuum. The chamber is connected to sieve by a plurality of air channels. Air inlets supply air to the underside of the sieve to agitate the material being sieved. A sieve case has a cover with apertures to permit more air to enter the sieve case to further agitate the material being sieved.
    Type: Grant
    Filed: May 25, 1979
    Date of Patent: April 14, 1981
    Inventors: Philip Edwards, Robert E. Spencer
  • Patent number: D579157
    Type: Grant
    Filed: April 17, 2007
    Date of Patent: October 21, 2008
    Inventor: Philip Edwards